Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apex Healthcare | Kuala Lumpur | Healthcare | Pharmaceuticals | MYR 1.46B | 18.5x | -0.23 | MYR 2.03 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 21.7% Upside | Upgrade to Pro+ | |
Duopharma Biotech | Kuala Lumpur | Healthcare | Pharmaceuticals | MYR 1.14B | 17x | 0.96 | MYR 1.18 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 26.1% Upside | Upgrade to Pro+ | |
Amway | Kuala Lumpur | Healthcare | Pharmaceuticals | MYR 844.94M | 8.7x | -0.5 | MYR 5.15 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 28.4% Upside | Upgrade to Pro+ | |
Kotra Industries | Kuala Lumpur | Healthcare | Pharmaceuticals | MYR 585.84M | 14.6x | -0.51 | MYR 3.95 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 29.1% Upside | Upgrade to Pro+ | |
Pharmaniaga Bhd | Kuala Lumpur | Healthcare | Pharmaceuticals | MYR 345.90M | 2.7x | 0.01 | MYR 0.24 | 2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
YSP Southeast Asia | Kuala Lumpur | Healthcare | Pharmaceuticals | MYR 297.87M | 11.1x | -0.38 | MYR 2.10 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Rhone Ma | Kuala Lumpur | Healthcare | Pharmaceuticals | MYR 132.74M | 10.4x | 6.43 | MYR 0.60 | -6.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 9.4% Upside | Upgrade to Pro+ | |
Bioalpha | Kuala Lumpur | Healthcare | Pharmaceuticals | MYR 42.19M | -0.8x | 0.12 | MYR 0.03 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |